Compounds for the treatment of metabolic disorders

Details for Australian Patent Application No. 2006311266 (hide)

Owner Wellstat Therapeutics Corporation

Inventors Wolpe, Stephen D.; Sharma, Shalini; Von Borstel, Reid W.; Romantsev, Fedor Evgenievich

Agent FB Rice

Pub. Number AU-B-2006311266

PCT Pub. Number WO2007/056771

Priority 60/734,803 09.11.05 US

Filing date 9 November 2006

Wipo publication date 18 May 2007

Acceptance publication date 29 September 2011

International Classifications

C07C 69/76 (2006.01) Esters of carboxylic acids

A61K 31/195 (2006.01)

A61K 31/235 (2006.01)

Event Publications

8 May 2008 PCT application entered the National Phase

  PCT publication WO2007/056771 Priority application(s): WO2007/056771

29 September 2011 Application Accepted

  Published as AU-B-2006311266

2 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006311268-Syringe devices, components of syringe devices, and methods of forming components and syringe devices

2006311255-HCV-reactiveT cell receptors